• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Image-guided salvage radiotherapy improves outcomes in patients with prostate cancer

byCyrus AyubchaandTeddy Guo
June 3, 2021
in Chronic Disease, Imaging and Intervention, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. 3-year event-free survival rates were significantly greater in the 18F-fluciclovine-PET group compared to conventional imaging.

2. Adverse reactions and toxicity levels were similar between the two groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: In patients with prostate cancer, prostatectomies are often followed with adjuvant or salvage radiotherapy. Postprostatectomy radiotherapy has conventionally been guided with a bone scan plus CT or MRI, but the diagnostic yield of these modalities has been questioned. The value added by nuclear image studies in addition to conventional imaging modalities, such as MRI and CT, has been of significant conversation. This study sought to assess the practical value added by the 18F-fluciclovine-PET/CT guided imaging in salvage radiotherapy treatment of prostate cancer. This randomized control trial found a significant improvement in event-free survival among those who received 18F-fluciclovine-PET imaging in addition to conventional imaging to guide radiotherapy. This was attributed to superior localization of the malignant lesions to be targeted by radiotherapy techniques. The study is most strengthened by its randomized control structure which better allows one to suggest that the observed differences were attributable to the additional imaging. Nevertheless, the most significant weaknesses involve the subjective interpretation of the imaging along with the variable subsequent use of the imaging in the development of radiotherapy.

Click to read the study in the Lancet

Relevant Reading: Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

In-Depth [randomized controlled trial]: This single center randomized control trial included patients with prostate adenocarcinoma with detectable PSA after prostatectomy and no metastasis. Patients with previous pelvic radiotherapy, medically-ineligible for radiotherapy or previous malignancy within the last 3 years were considered ineligible. Patients were randomized between the treatment group (n=83) and the control group (n=82). The treatment entailed 18F-­fluciclovine­-PET/CT imaging in addition to conventional imaging with either CT and MRI; the subsequent radiotherapy decisions were determined by 18F­-fluciclovine-­PET, MRI, or CT imaging findings for each patient. Subsequent to therapy, the patients continued to receive appropriate medical care such as androgen-deprivation therapy. Patients assessed at 1-, 6-, 12-, 18-, 24-, 30-, and 36-month intervals after radiotherapy treatment with PSA levels and physical examinations. Univariable determined that the 3-year event-free survival was 63.0% (95% CI 49.2-74.0) and 75.5% (95% CI 62.5-84.6) in the control and treatment groups, respectively (p= 0.003). Multivariable analyses also showed that the 18F­fluciclovine­PET group was associated with improved event-free survival (hazard ratio 2.04 [95% CI 1.06–3.93], p=0.0327). Similar trends were replicated in PSA analyses where 18F­-fluciclovine-­PET/CT was linked to decreased PSA levels after radiotherapy treatment.

RELATED REPORTS

Plant-based diets may be associated with lower risk of aggressive prostate cancer

Wellness Check: Nutrition

#VisualAbstract: Positive prostate MRI and targeted biopsy reduce the detection of clinically insignificant prostate cancer

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: 18F-fluciclovine18F-fluciclovine-PET/CTPET scanPositron Emission Tomography (PET Scan)prostateprostate cancerprostate specific antigenprostate specific antigen (PSA)prostatectomyradiotherapysalvage radiotherapy
Previous Post

#VisualAbstract: Risk factors associated with speech and voice impairment in long-term survivors of oropharyngeal cancer

Next Post

#VisualAbstract Phase 2 trial shows umbralisib is safe and effective in patients with chronic lymphocytic leukemia who are intolerant to BTK or PI3Kδ inhibitor therapy

RelatedReports

Vegetarian diet may lower incidence of colorectal cancer
Lifestyle

Plant-based diets may be associated with lower risk of aggressive prostate cancer

January 27, 2023
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets
Wellness

Wellness Check: Nutrition

January 26, 2023
#VisualAbstract: Positive prostate MRI and targeted biopsy reduce the detection of clinically insignificant prostate cancer
StudyGraphics

#VisualAbstract: Positive prostate MRI and targeted biopsy reduce the detection of clinically insignificant prostate cancer

January 4, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 2

November 22, 2022
Next Post
#VisualAbstract Phase 2 trial shows umbralisib is safe and effective in patients with chronic lymphocytic leukemia who are intolerant to BTK or PI3Kδ inhibitor therapy

#VisualAbstract Phase 2 trial shows umbralisib is safe and effective in patients with chronic lymphocytic leukemia who are intolerant to BTK or PI3Kδ inhibitor therapy

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Early initiation of rhythm-control for atrial fibrillation associated with lower risk of adverse cardiovascular outcomes

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

2 Minute Medicine Rewind June 7, 2021

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Rocatinlimab may be effective in the treatment of moderate-to-severe atopic dermatitis
  • Gender-affirming hormones improve psychosocial functioning in transgender youth
  • Left atrial reservoir strain improves ischemic stroke risk prediction in low-risk patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options